The Aflac Cancer & Blood Disorders Center has 125 faculty members and approximately 50 Advance Practice Providers (APPs) conducting basic, translational, and clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, hemoglobinopathies and hemophilia.